咨询与建议

看过本文的还看了

相关文献

该作者的其他文献

文献详情 >Mesenchymal stem cell secretom... 收藏

Mesenchymal stem cell secretome and nanotechnology:Combining therapeutic strategies

作     者:ADRIANA L.FERREIRA GUSTAVO C.PARIS ALINE DE A.AZEVEDO ERIKA A.C.CORTEZ SIMONE N.CARVALHO LAIS DE CARVALHO ALESSANDRA A.THOLE 

作者机构:Laboratory of Stem Cell ResearchRoberto Alcantara Gomes Biology InstituteRio de Janeiro State UniversityRio de Janeiro20540170Brazil 

出 版 物:《BIOCELL》 (生物细胞(英文))

年 卷 期:2022年第46卷第8期

页      面:1807-1813页

核心收录:

学科分类:1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学] 

基  金:This study was financed in part by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior-Brasil(CAPES)-Finance Code 001 the“Conselho Nacional de Desenvolvimento Científico e Tecnológico(CNPq)” the“Fundação Carlos Chagas Filho de AmparoàPesquisa do Estado do Rio de Janeiro(FAPERJ)” 

主  题:Mesenchymal stem cells Nanoparticles Secretome Exosome Targeted drug delivery 

摘      要:Mesenchymal stem cells(MSC)have pushed the field of stem cell-based therapies by inducing tissue regeneration,immunosuppression,and angiogenesis mainly through vesicles and soluble factors release(paracrine signaling).MSC-extracellular vesicles(MSC-EV)adaptable secretome and homing to injured sites allowed researchers to unlock a new era of cell-free based *** parallel,nanoparticles(NP)have been explored in contributing to transport and drug delivery systems,giving drugs desired physical-chemical properties to exploit cell ***,NPs can be quickly recognized by immune cells and cleared from *** this viewpoint,we explore how combining both therapeutic strategies can improve efficacy and circumvent limitations of both *** benefit from the potent MSC membrane composition,guiding chemotaxis to tumor sites,a very restricted ***-EV has low immunogenicity,high stability,long half-life and can explore tissue targeting ligands as a precise drug carry,even across biological *** properties promote enhanced targeted drug delivery that can be combined with NP,exploring biological membrane production through:*** cell therapy with NP-infused MSC;***-containing MSC-EV generated by NP-infused MSC;*** coating NP in MSC membrane(“MSC NanoGhosts),allowing precise cargo definition without losing ***,nanotechnology combined with cell-based therapeutic resources can greatly improve targeted drug delivery,improving efficacy and opening a new venue of therapeutic possibilities.

读者评论 与其他读者分享你的观点

用户名:未登录
我的评分